PTPRN2 and breast carcinoma: Knockdown of PTPRN2 or PLCβ1 in four other breast cancer cell lines (BT‐549, CNLM1a, HCC‐1806, and MDA‐MB‐468) also significantly reduced the migratory capacity of these cells (Appendix Fig S2E–L).